AnaBios generates highly valuable, predictive human data in advance of clinical trials, ensuring the selection of the most effective and safest drugs, thereby reducing the time and expense related to clinical trial failures. Through its proprietary technology, based on the use of human donor organs and tissues, AnaBios studies ex-vivo human responses to drugs and further investigates the molecular and functional basis of relevant human physiology. AnaBios's research focuses primarily on the areas of high, unmet medical need, including cardiac disease and safety, pain, PKD kidney disease and neurodegeneration. AnaBios partners and works with global Fortune 500 pharmaceutical companies, CRO's and universities. Located in San Diego, California, AnaBios markets its products and services directly, as well as through distributors and partners worldwide. AnaBios also drives an internal drug discovery platform via in-licensed programs from partners in the pharmaceutical industry and academia.